197 related articles for article (PubMed ID: 16328384)
1. Inhibition of nuclear factor kappa B (NFkappaB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation.
Jewett A; Cacalano NA; Teruel A; Romero M; Rashedi M; Wang M; Nakamura H
Cancer Immunol Immunother; 2006 Sep; 55(9):1052-63. PubMed ID: 16328384
[TBL] [Abstract][Full Text] [Related]
2. Cytokine dependent inverse regulation of CD54 (ICAM1) and major histocompatibility complex class I antigens by nuclear factor kappaB in HEp2 tumor cell line: effect on the function of natural killer cells.
Jewett A; Wang MY; Teruel A; Poupak Z; Bostanian Z; Park NH
Hum Immunol; 2003 May; 64(5):505-20. PubMed ID: 12691701
[TBL] [Abstract][Full Text] [Related]
3. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
Jewett A; Teruel A; Romero M; Head C; Cacalano N
Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
[TBL] [Abstract][Full Text] [Related]
4. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
Jewett A; Bonavida B
Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
[TBL] [Abstract][Full Text] [Related]
5. Activation of c-Jun N-terminal kinase in the absence of NFkappaB function prior to induction of NK cell death triggered by a combination of anti-class I and anti-CD16 antibodies.
Jewett A
Hum Immunol; 2001 Apr; 62(4):320-31. PubMed ID: 11295464
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase Btk is required for NK cell activation.
Bao Y; Zheng J; Han C; Jin J; Han H; Liu Y; Lau YL; Tu W; Cao X
J Biol Chem; 2012 Jul; 287(28):23769-78. PubMed ID: 22589540
[TBL] [Abstract][Full Text] [Related]
7. Potent induction of TNF-alpha during interaction of immune effectors with oral tumors as a potential mechanism for the loss of NK cell viability and function.
Romero-Reyes M; Head C; Cacalano NA; Jewett A
Apoptosis; 2007 Nov; 12(11):2063-75. PubMed ID: 17713857
[TBL] [Abstract][Full Text] [Related]
8. Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion.
Teruel A; Romero M; Cacalano NA; Head C; Jewett A
Cancer Immunol Immunother; 2008 Mar; 57(3):359-66. PubMed ID: 17703300
[TBL] [Abstract][Full Text] [Related]
9. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12.
Kranzer K; Bauer M; Lipford GB; Heeg K; Wagner H; Lang R
Immunology; 2000 Feb; 99(2):170-8. PubMed ID: 10692033
[TBL] [Abstract][Full Text] [Related]
10. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness.
Ziblat A; Domaica CI; Spallanzani RG; Iraolagoitia XL; Rossi LE; Avila DE; Torres NI; Fuertes MB; Zwirner NW
Eur J Immunol; 2015 Jan; 45(1):192-202. PubMed ID: 25308526
[TBL] [Abstract][Full Text] [Related]
11. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii.
Tato CM; Villarino A; Caamaño JH; Boothby M; Hunter CA
J Immunol; 2003 Mar; 170(6):3139-46. PubMed ID: 12626571
[TBL] [Abstract][Full Text] [Related]
13. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.
Jewett A; Bonavida B
J Clin Immunol; 1995 Jan; 15(1):35-44. PubMed ID: 7759599
[TBL] [Abstract][Full Text] [Related]
15. Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.
Michelo CM; Fasse E; van Cranenbroek B; Linda K; van der Meer A; Abdelrazik H; Joosten I
Transpl Immunol; 2016 Jul; 37():1-9. PubMed ID: 27142560
[TBL] [Abstract][Full Text] [Related]
16. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
[TBL] [Abstract][Full Text] [Related]
17. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
18. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
19. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
